Power Law company profile

OrganOx

Health Tech & Medtech · Oxford, United Kingdom · Founded 2008 Unicorn

Normothermic organ perfusion system for liver transplantation

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Revenue

$50–100M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

16 investors on OrganOx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Oxford Technology

Adam Niewinski

Technikos

Series B+ 13 investors entered at this stage

Piper Heartland Healthcare Capital

Intuitive Ventures

Royal Society Enterprise Fund

Longwall Ventures

University of Oxford

Business Growth Fund

Oxford University Innovation

Avidity Partners

Soleus Capital

HealthQuest Capital

Sofina

Lauxera Capital Partners

Terumo Corporation

Global footprint

Where OrganOx has talent and traffic

AI talent share

0.5% of workforce is AI talent
(1 of 216 staff)

Core AI10.46%

Other AI00%

Non-AI workforce21599.54%

Workforce by country

5 countries with
team presence

🇬🇧 United Kingdom53.2%

🇺🇸 United States44%

🇩🇪 Germany1.3%

🇫🇷 France1%

🇨🇭 Switzerland0.6%

5 countries shown

Web traffic by country

9.6K monthly visits
across markets

🇺🇸 United States51%

🇬🇧 United Kingdom30.2%

🇮🇳 India19.8%

Top 3 markets shown

Market sentiment

What the market is saying about OrganOx

An AI-synthesized read of the highest-engagement posts about OrganOx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See OrganOx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles